Acute myeloid leukemia (AML) is a form of cancer that is common in older patients. Mutations in the isocitrate dehydrogenase enzyme 2 (IDH2) have been found in approximately 15% of patients with AML.
Clinical Trial Information
Trial Contact: Rompola, Melissa; Ferry, Robert, P.
Age Group: Adult
Phase: Drug: Phase III
Principal Investigator: Daniel Ari Landau, MD
IRB No: 16.042.03
Secondary Protocol No: IDHENTIFY
Applicable Disease Sites: Leukemia, Myeloid, Isocitrate Dehydrogenase